Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Does miR-199a-3p Regulate Stearoyl-CoA Desaturase 1 (SCD1) in Ovine Tissues or Subcutaneous Adipocytes? Evidence for Species-Specific Differences.

Udoka ANS., Duckett SK.

Laboratory Study with a reported sample of 4 on Hip, published in Microrna (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Microrna (2026)
Country
United Arab Emirates
Reported sample size
4
Source database
PubMed
PMID
42517386
DOI
10.2174/0122115366480003260708191849

Abstract (original English)

Introduction Stearoyl-CoA desaturase 1 (SCD1) is a key enzyme in the conversion of saturated (SFA) to monounsaturated fatty acids (MUFA) that alters the fatty acid composition of adipose tissues. We hypothesize that miR-199a-3p regulates stearoyl-CoA desaturase 1 (SCD1) expression and MUFA concentration in ovine adipose tissues and subcutaneous primary adipocytes in vitro. The objectives were to: 1) examine the relationship between miR-199a-3p and SCD1 expression, and MUFA fatty acid concentration in adipose tissues of lambs from two sire breeds, and 2) evaluate overexpression (AgomiR-199a-3p) and knockdown (AntagomiR-199a-3p) of miR-199a-3p on SCD1 mRNA expression and MUFA content in subcutaneous adipocytes in vitro. Methods Adipose tissue samples were collected from lambs sired by two breed types (n = 4/sire breed). miR-199a-3p and SCD1 mRNA expression, and MUFA: SFA ratio were examined in five adipose depots. Stromal vascular fraction (SVF) cells were isolated from subcutaneous adipose tissues, propagated, and used to examine overexpression (AgomiR-199a-3p) or knockdown (An-tagomiR-199a-3p) of miR-199a-3p on SCD1 expression. Results Expression of miRNA-199a-3p and SCD1 mRNA differed in adipose tissues by sire breed. AgomiR-199a-3p or antagomir-199a-3p treatments did not alter SCD1 mRNA expression or MUFA content; however, the magnitude of the downregulation of miR-199a-3p wi

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research